Standard rescue medication adjustments produce biased estimates of analgesic efficacy: reducing bias with multiple imputation for rescue adjustment (MIRA)
Abstract
Abstract: Acute pain trials rely on imputation procedures to handle the confounding impact of rescue medication on pain scores. Despite long-standing concerns about the bias of single-imputation procedures such as last-, baseline-, and worst-observation carried forward (LOCF, BOCF, WOCF), they remain the standard approaches for rescue adjustment in analgesic trials. To evaluate their performance characteristics, we conducted a data-driven simulation study informed by bunionectomy trials submitted to the U.S. Food and Drug Administration. Our study demonstrates that single-imputation procedures systematically overestimate pain scores after rescue medication use, which produces biased pain curves over time and inaccurate estimates of onset of effect. Because rescue use varies by treatment effectiveness, the direction and magnitude of treatment-effect bias depend on the imputation method. In simulated trials, treatment effects on the sum of pain intensity differences were overestimated by 6% to 7% with LOCF and by 31% to 34% with WOCF and underestimated by 2% to 14% with BOCF depending on the effect size. To address this, we developed Multiple Imputation for Rescue Adjustment (MIRA), a reference-based procedure that uses historical efficacy data on an analgesic to adjust pain scores reported after its use as rescue medication. Multiple Imputation for Rescue Adjustment recovered approximately unbiased estimates under correctly specified simulation conditions and was robust to…
Read the paper
Related studies
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
- Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
- Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience
- Celecoxib or naproxen treatment does not benefit depressive symptoms in persons aged 70 and over: findings from a randomized controlled trial
- Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial
- Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.